Published in Circulation on August 09, 2010
Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol (2013) 1.97
Role of plasma kallikrein in diabetes and metabolism. Thromb Haemost (2013) 1.22
In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity. Integr Biol (Camb) (2012) 1.11
Splice variants of tissue factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signaling. J Thromb Haemost (2011) 1.05
Restenosis and therapy. Int J Vasc Med (2012) 0.83
Factor XI Deficiency Protects Against Atherogenesis in Apolipoprotein E/Factor XI Double Knockout Mice. Arterioscler Thromb Vasc Biol (2016) 0.82
Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice. Drug Des Devel Ther (2015) 0.79
Evaluation of various endothelial biomarkers in ankylosing spondylitis. Clin Rheumatol (2011) 0.78
VKORC1 rs2359612C allele is associated with increased risk of coronary artery disease in the presence of coronary calcification. Hum Genet (2012) 0.78
Syndecan-1 regulates vascular smooth muscle cell phenotype. PLoS One (2014) 0.78
Sphingosine-1-Phosphate and Its Receptors: A Mutual Link between Blood Coagulation and Inflammation. Mediators Inflamm (2015) 0.76
Antithrombin nanoparticles inhibit stent thrombosis in ex vivo static and flow models. J Vasc Surg (2015) 0.76
Thrombin Generation and Atherothrombosis: What Does the Evidence Indicate? J Am Heart Assoc (2016) 0.76
Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis. Arterioscler Thromb Vasc Biol (2016) 0.75
"Soluble Tissue Factor" in the 21st Century: Definitions, Biochemistry, and Pathophysiological Role in Thrombus Formation. Semin Thromb Hemost (2015) 0.75
Association between Stable Coronary Artery Disease and In Vivo Thrombin Generation. Cardiol Res Pract (2016) 0.75
A Rare Occurrence of Simultaneous Venous and Arterial Thromboembolic Events - Lower Limb Deep Venous Thrombosis and Pulmonary Thromboembolism as Initial Presentation in Acute Promyelocytic Leukemia. Clin Med Insights Oncol (2016) 0.75
Activated plasma coagulation β-Factor XII-induced vasoconstriction in rats. Clin Sci (Lond) (2012) 0.75
ON VASCULAR STENOSIS, RESTENOSIS AND MANNOSE BINDING LECTIN. Arq Bras Cir Dig (2016) 0.75
Parenteral administration of factor Xa/IIa inhibitors limits experimental aortic aneurysm and atherosclerosis. Sci Rep (2017) 0.75
Spermine and spermidine reversed age-related cardiac deterioration in rats. Oncotarget (2017) 0.75
Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress. Circulation (2006) 5.58
Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med (2010) 5.06
Nucleophilic catalysis of oxime ligation. Angew Chem Int Ed Engl (2006) 2.69
The hemostatic system as a modulator of atherosclerosis. N Engl J Med (2011) 2.54
Nucleophilic catalysis of hydrazone formation and transimination: implications for dynamic covalent chemistry. J Am Chem Soc (2006) 2.45
Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. Cell Metab (2010) 2.33
Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy. Circ Res (2004) 2.31
Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study. Ann Intern Med (2011) 2.28
Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J Am Coll Cardiol (2009) 2.26
Lactadherin promotes VEGF-dependent neovascularization. Nat Med (2005) 2.19
Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med (2009) 2.15
Dual role of collagen in factor XII-dependent thrombus formation. Blood (2009) 2.01
Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction. J Am Coll Cardiol (2008) 1.97
Cathepsin cysteine proteases in cardiovascular disease. FASEB J (2007) 1.92
Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood (2010) 1.86
Neutrophil-derived cathelicidin protects from neointimal hyperplasia. Sci Transl Med (2011) 1.84
Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis (2012) 1.79
Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol (2002) 1.69
Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation (2004) 1.69
Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype. Eur Heart J (2013) 1.67
Thrombotic risk during oral contraceptive use and pregnancy in women with factor V Leiden or prothrombin mutation: a rational approach to contraception. Blood (2011) 1.63
A disintegrin and metalloprotease 10 is a novel mediator of vascular endothelial growth factor-induced endothelial cell function in angiogenesis and is associated with atherosclerosis. Arterioscler Thromb Vasc Biol (2010) 1.63
Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood (2007) 1.62
Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling. JACC Cardiovasc Imaging (2009) 1.61
Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood (2004) 1.61
Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. J Clin Invest (2008) 1.59
Low molecular weight heparin attenuates multiple organ failure in a murine model of disseminated intravascular coagulation. Crit Care Med (2005) 1.58
Endothelial activation in lacunar stroke subtypes. Stroke (2010) 1.55
Gene expression profiling identifies C/EBPdelta as a candidate regulator of endotoxin-induced disseminated intravascular coagulation. Am J Respir Crit Care Med (2007) 1.54
Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A. Circulation (2010) 1.50
Tumor cells secrete galectin-1 to enhance endothelial cell activity. Cancer Res (2010) 1.50
NFATc2 is a necessary mediator of calcineurin-dependent cardiac hypertrophy and heart failure. J Biol Chem (2008) 1.50
Infection and inflammation and the coagulation system. Cardiovasc Res (2003) 1.49
Mouse strain determines the outcome of wound healing after myocardial infarction. Cardiovasc Res (2009) 1.49
Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model. Crit Care (2014) 1.49
Patients with antineutrophil cytoplasmic antibodies associated vasculitis in remission are hypercoagulable. J Rheumatol (2013) 1.49
Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage. Am J Pathol (2006) 1.46
Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice. Am J Physiol Heart Circ Physiol (2002) 1.45
MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction. Circ Res (2004) 1.39
In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation. Nat Med (2011) 1.38
Angiotensin-converting enzyme and vascular remodeling. Circ Res (2007) 1.36
Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon. Arch Intern Med (2004) 1.35
Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med (2004) 1.34
The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res (2008) 1.34
The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling. Blood (2008) 1.29
Beneficial effects of vitamins D and K on the elastic properties of the vessel wall in postmenopausal women: a follow-up study. Thromb Haemost (2004) 1.28
Prolonged shear stress and KLF2 suppress constitutive proinflammatory transcription through inhibition of ATF2. Blood (2007) 1.27
Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood (2006) 1.24
Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: differences between calvaria and long bone. J Bone Miner Res (2006) 1.21
Tissue factor in infection and severe inflammation. Semin Thromb Hemost (2006) 1.20
Is thrombin a key player in the 'coagulation-atherogenesis' maze? Cardiovasc Res (2009) 1.20
Irradiation induced modest changes in murine cardiac function despite progressive structural damage to the myocardium and microvasculature. Radiother Oncol (2011) 1.19
Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung injury. Am J Respir Crit Care Med (2012) 1.18
Fn14-Fc fusion protein regulates atherosclerosis in ApoE-/- mice and inhibits macrophage lipid uptake in vitro. Arterioscler Thromb Vasc Biol (2009) 1.18
Endothelial junctional adhesion molecule-a guides monocytes into flow-dependent predilection sites of atherosclerosis. Circulation (2013) 1.18
Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases. Blood (2009) 1.17
Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin. Blood (2011) 1.15
Activated protein C protects against myocardial ischemia/ reperfusion injury via inhibition of apoptosis and inflammation. Arterioscler Thromb Vasc Biol (2009) 1.15
In vivo detection of hemorrhage in human atherosclerotic plaques with magnetic resonance imaging. J Magn Reson Imaging (2004) 1.14
The wnt-frizzled cascade in cardiovascular disease. Cardiovasc Res (2002) 1.14
Cerebral white matter lesions predict both ischemic strokes and myocardial infarctions in patients with established atherosclerotic disease. Atherosclerosis (2005) 1.14
Assessment of human atherosclerotic carotid plaque components with multisequence MR imaging: initial experience. Radiology (2005) 1.14
Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction. Cardiovasc Pathol (2008) 1.12
Molecular MRI of early thrombus formation using a bimodal alpha2-antiplasmin-based contrast agent. JACC Cardiovasc Imaging (2009) 1.12
CD40-CD40L interactions in atherosclerosis. Trends Cardiovasc Med (2002) 1.11
Gene profiling in atherosclerosis reveals a key role for small inducible cytokines: validation using a novel monocyte chemoattractant protein monoclonal antibody. Circulation (2005) 1.11
Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department. Crit Care Med (2010) 1.11
The hemostatic balance in HIV-infected patients with and without antiretroviral therapy: partial restoration with antiretroviral therapy. AIDS Patient Care STDS (2009) 1.11
Cardiovascular risks in spondyloarthritides. Curr Opin Rheumatol (2007) 1.10
Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients. Life Sci (2004) 1.09
The multi-functionality of CD40L and its receptor CD40 in atherosclerosis. Thromb Haemost (2009) 1.09
Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera. Blood (2008) 1.08
Novel insights into pathological changes in muscular arteries of radiotherapy patients. Radiother Oncol (2009) 1.08
Atherosclerotic plaque rupture: local or systemic process? Arterioscler Thromb Vasc Biol (2003) 1.08
Endothelium: interface between coagulation and inflammation. Crit Care Med (2002) 1.06